Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Post by FullReversalon Oct 10, 2016 1:55pm
129 Views
Post# 25328407

Understanding the origins of all these old drugs

Understanding the origins of all these old drugs
Researching Concordia's #1 drug, Donnatal is fascinating.

Was a drug acquired by PBM Pharmaceuticals in the US, now called Revive. A non-public company.

The company's web site clearly states their mission;

"At Revive we identify pharmaceuticals with long histories of efficacy and reintroduce them to the market with reinvigorated marketing and sales support..."

They did that with Donnatal, even if the FDA has not found it to be a valid medication for the condition and it on it's hit list. Health Canada doesn't even allow it to be made available in Canada.

After "reinvigorating" Donnatal through price hikes that patients all over the net are complaining about, they sold it to Concordia in 2014 for cash and shares.

https://revivepharma.com/concordia-healthcare-announces-agreement-to-acquire-donnatal/

<< Previous
Bullboard Posts
Next >>